CombiChem

CombiChem was a pioneering biotechnology company specializing in combinatorial chemistry and computational drug discovery. Founded in 1994 and headquartered in San Diego, the company developed the Discovery Engine, a platform that integrated high-throughput chemical synthesis with computer-aided design to rapidly identify lead small molecule candidates. The company's business model focused on providing drug discovery services and technology access to major pharmaceutical partners, including Roche and Bristol Myers Squibb. CombiChem went public in 1998 and was subsequently acquired by DuPont Pharmaceuticals in 1999 for approximately 95 million dollars. Its legacy remains as a foundational player in the evolution of modern high-throughput lead optimization.